1
|
Wright EM, Hirayama BA and Loo DF: Active
sugar transport in health and disease. J Intern Med. 261:32–43.
2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kanai Y, Lee WS, You G, Brown D and
Hediger MA: The human kidney low affinity Na+/glucose cotransporter
SGLT2. Delineation of the major renal reabsorptive mechanism for
D-glucose. J Clin Invest. 93:397–404. 1994. View Article : Google Scholar : PubMed/NCBI
|
3
|
van den Heuvel LP, Assink K, Willemsen M
and Monnens L: Autosomal recessive renal glucosuria attributable to
a mutation in the sodium glucose cotransporter (SGLT2). Hum Genet.
111:544–547. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Santer R, Kinner M, Lassen CL,
Schneppenheim R, Eggert P, Bald M, Brodehl J, Daschner M, Ehrich
JH, Kemper M, et al: Molecular analysis of the SGLT2 gene in
patients with renal glucosuria. J Am Soc Nephrol. 14:2873–2882.
2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Calado J, Soto K, Clemente C, Correia P
and Rueff J: Novel compound heterozygous mutations in SLC5A2 are
responsible for autosomal recessive renal glucosuria. Hum Genet.
114:314–316. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kleta R, Stuart C, Gill FA and Gahl WA:
Renal glucosuria due to SGLT2 mutations. Mol Genet Metab. 82:56–58.
2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Francis J, Zhang J, Farhi A, Carey H and
Geller DS: A novel SGLT2 mutation in a patient with autosomal
recessive renal glucosuria. Nephrol Dial Transplant. 19:2893–2895.
2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Magen D, Sprecher E, Zelikovic I and
Skorecki K: A novel missense mutation in SLC5A2 encoding SGLT2
underlies autosomal-recessive renal glucosuria and aminoaciduria.
Kidney Int. 67:34–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Calado J, Loeffler J, Sakallioglu O, Gok
F, Lhotta K, Barata J and Rueff J: Familial renal glucosuria:
SLC5A2 mutation analysis and evidence of salt-wasting. Kidney Int.
69:852–855. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Calado J, Sznajer Y, Metzger D, Rita A,
Hogan MC, Kattamis A, Scharf M, Tasic V, Greil J, Brinkert F, et
al: Twenty-one additional cases of familial renal glucosuria:
Absence of genetic heterogeneity, high prevalence of private
mutations and further evidence of volume depletion. Nephrol Dial
Transplant. 23:3874–3879. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yu L, Lv JC, Zhou XJ, Zhu L, Hou P and
Zhang H: Abnormal expression and dysfunction of novel SGLT2
mutations identified in familial renal glucosuria patients. Hum
Genet. 129:335–344. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee H, Han KH, Park HW, Shin JI, Kim CJ,
Namgung MK, Kim KH, Koo JW, Chung WY, Lee DY, et al: Familial renal
glucosuria: A clinicogenetic study of 23 additional cases. Pediatr
Nephrol. 27:1091–1095. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee YW: Clinical and genetic analysis in a
patient with primary renal glucosuria: Identification of a novel
mutation in the SLC5A2 gene. Exp Ther Med. 6:1532–1534. 2013.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Yu L, Hou P, Lv JC, Liu GP and Zhang H: A
novel sodium-glucose co-transporter 2 gene (SGLT2) mutation
contributes to the abnormal expression of SGLT2 in renal tissues in
familial renal glucosuria. Int Urol Nephrol. 46:2237–2238. 2014.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Yu L, Hou P, Lv JC, Liu GP and Zhang H:
Novel SLC5A2 variants contribute to renal glucosuria in Chinese
families: Abnormal expression and dysfunction of variant SLC5A2.
Hum Mutat. 36:79–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Dhayat N, Simonin A, Anderegg M, Pathare
G, Lüscher BP, Deisl C, Albano G, Mordasini D, Hediger MA, Surbek
DV, et al: Mutation in the monocarboxylate transporter 12 gene
affects guanidinoacetate excretion but does not cause glucosuria. J
Am Soc Nephrol. 27:1426–1436. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ottosson-Laakso E, Tuomi T, Forsén B,
Gullström M, Groop PH, Groop L and Vikman P: Influence of familial
renal glycosuria due to mutations in the SLC5A2 gene on changes in
glucose tolerance over Time. PLoS One. 11:e01461142016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yu L, Xu Q, Hou P and Zhang H: Decreased
expression and function of sodium-glucose co-transporter 2 from a
novel C-terminal mutation: A case report. BMC Nephrol. 17:312016.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Yu L, Hou P, Liu GP and Zhang H: Novel
SLC5A2 mutation contributes to familial renal glucosuria: Abnormal
expression in renal tissues. Exp Ther Med. 12:649–652. 2016.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhao X, Cui L, Lang Y, Liu T, Lu J, Wang
C, Tuffery-Giraud S, Bottillo I, Wang X and Shao L: A recurrent
deletion in the SLC5A2 gene including the intron 7 branch site
responsible for familial renal glucosuria. Sci Rep. 6:339202016.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Kim KM, Kwon SK and Kim HY: A Case of
Isolated Glycosuria Mediated by an SLC5A2 gene mutation and
characterized by postprandial heavy glycosuria without salt
wasting. Electrolyte Blood Press. 14:35–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang X, Yu M, Wang T, Zhang H, Ping F,
Zhang Q, Xu J, Feng K and Xiao X: Genetic analysis and literature
review of Chinese patients with familial renal glucosuria:
Identification of a novel SLC5A2 mutation. Clin Chim Acta.
469:105–110. 2017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Crombie DL: Incidence of glucosuria and
diabetes. Proc R Soc Med. 55:205–207. 1962.PubMed/NCBI
|
24
|
Urakami T, Yoda M, Yoshida K, Mine Y, Aoki
M and Suzuki J: Renal glucosuria in schoolchildren: Clinical
characteristics. Pediatr Int. 60:35–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
25
|
Santer R and Calado J: Familial renal
glucosuria and SGLT2: From a mendelian trait to a therapeutic
target. Clin J Am Soc Nephrol. 5:133–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Scholl-Burgi S, Santer R and Ehrich JH:
Long-term outcome of renal glucosuria type O: The original patient
and his natural history. Nephrol Dial Transplant. 19:2394–2396.
2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Wright EM: Renal Na(+)-glucose
cotransporters. Am J Physiol Renal Physiol. 280:F10–F18. 2001.
View Article : Google Scholar : PubMed/NCBI
|
28
|
De Marchi S, Cecchin E, Basile A, Proto G,
Donadon W, Jengo A, Schinella D, Jus A, Villalta D, De Paoli P, et
al: Close genetic linkage between HLA and renal glycosuria. Am J
Nephrol. 4:280–286. 1984. View Article : Google Scholar : PubMed/NCBI
|
29
|
Hou J, van Leeuwen J, Andrews BJ and Boone
C: Genetic network complexity shapes background-dependent
phenotypic expression. Trends Genet. 34:578–586. 2018. View Article : Google Scholar : PubMed/NCBI
|
30
|
Panayotova-Heiermann M, Loo DD, Kong CT,
Lever JE and Wright EM: Sugar binding to Na+/glucose cotransporters
is determined by the carboxyl-terminal half of the protein. J Biol
Chem. 271:10029–10034. 1996. View Article : Google Scholar : PubMed/NCBI
|
31
|
Freitas HS, D'Agord Schaan B, da Silva RS,
Okamoto MM, Oliveira-Souza M and Machado UF: Insulin but not
phlorizin treatment indu ces a transient increase in GLUT2 gene
expression in the kidney of diabetic rats. Nephron Physiol.
105:p42–p51. 2007. View Article : Google Scholar : PubMed/NCBI
|
32
|
Alicic RZ, Johnson EJ and Tuttle KR: SGLT2
Inhibition for the prevention and treatment of diabetic kidney
disease: A review. Am J Kidney Dis. 72:267–277. 2018. View Article : Google Scholar : PubMed/NCBI
|